Our Experts Are Your Experts
Expert Community offers insight and analysis on timely topics through articles, white papers and multimedia presentations from PPD’s biopharmaceutical industry thought leaders. Through this robust collection, PPD addresses the most pressing questions facing the clinical research industry.
In this article, PPD experts note that a number of non-traditional statistical approaches should be considered when developing biosimilars.
A PPD expert was featured in an article that looks at the development of orphan drugs.
An expert from our cGMP labs team discusses pulmonary drug delivery and the key formulation considerations when developing an inhalation drug.